Given that the impact of p27 can be disrupted in human cancers by excess proteolysis, C-terminal phosphorylation, or reduced translation, we found that deletion of MESP2 leading to p27 downregulation was due to SKP2-mediated ubiquitination through the proteasome pathway. This evidence concerns the gene SKP2 and cancer.